Sun Pharma Among Nifty’s Biggest Losers After USFDA Put Partial Clinical Trial on Deuruxolitinib Drug
Shares of Sun Pharmaceutical Industries fell more than 1% on May 2 after the US Food and Drug Administration (USFDA) suspended part of its clinical...